ENTRY       D11878                      Drug
NAME        Bulevirtide acetate;
            Hepcludex (TN)
REMARK      ATC code: J05AX28
            Chemical structure group: DG03116
EFFICACY    Antiviral, Entry inhibitor
  DISEASE   Hepatitis delta virus infection [DS:H00414]
TARGET      HDV antigen
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AX Other antivirals
                 J05AX28 Bulevirtide
                  D11878  Bulevirtide acetate
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Hepatitis virus antigen
                D11878  Bulevirtide acetate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11878
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11878
///
